Previous close | 1.7600 |
Open | 1.8400 |
Bid | 1.8200 x 600 |
Ask | 1.8500 x 300 |
Day's range | 1.8250 - 1.9900 |
52-week range | 1.1200 - 3.9010 |
Volume | |
Avg. volume | 756,087 |
Market cap | 260.857M |
Beta (5Y monthly) | 3.07 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.6800 |
Earnings date | 09 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 2.75 |
BRANFORD, Conn., April 30, 2024--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced upgrades to its Platinum® Analysis Software to reduce processing time and increase output and precision of Next-Generation Protein Sequencing™ (NGPS) data from the Platinum® instrument.
BRANFORD, Conn., April 18, 2024--Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
BRANFORD, Conn., March 21, 2024--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors.